Often, pharmaceutical companies avoid new laboratory testing methodologies preferring to stick to established procedures for drug development so as to avoid any potential regulatory ambiguity. This tendency to avoid new methodologies and regulatory scrutiny sometimes leads to slower progress, higher costs and lower probability of new product approvals. Furthermore, some pharmaceutical firms severely restrict academic research-based modifications to established laboratory testing procedures in drug development because of their concern over triggering costly adjustments to the established regulatory framework.
Viventia is developing and advancing the next generation of human antibody-based therapeutics for use in oncology. Our approach combines the specificity of an antibody with the potency of a cytotoxic payload to provide targeted therapies for the safer and more efficacious treatment of cancer patients. Viventia has developed a potent payload, deBouganin, that when coupled to a targeting antibody can effectively kill cancer cells without harming normal cells. This differential targeting enhances the therapeutic potential of our drugs and provides prolonged clinical benefit. The versatile deBouganin payload has been chemically conjugated to full length antibodies as well as fused to numerous antibody fragments and has been found to be safe and efficacious in the clinic.
CardioGenics is dedicated to develop more sensitive diagnostic test products to the IVD market. CardioGenics has started several developmental processes aimed to achieve its objective 'to create, develop and commercialize superior, innovative, cost-effective and patent-protected products for the IVD based on proprietary technologies'.CardioGenics' operating philosophy is that 'better diagnosis enhances the healthcare professionals' ability to provide better patient management which saves lives and reduces healthcare costs'. Fulfilling unmet clinical testing needs is the driving force behind CardioGenics' innovations.
CardioGenics is dedicated to develop more sensitive diagnostic test products to the IVD market. CardioGenics has started several developmental processes aimed to achieve its objective 'to create, develop and commercialize superior, innovative, cost-effective and patent-protected products for the IVD based on proprietary technologies'. operating philosophy is that 'better diagnosis enhances the healthcare professionals' ability to provide better patient management which saves lives and reduces healthcare costs'. Fulfilling unmet clinical testing needs is the driving force behind CardioGenics' innovations.
Sky Teck Labs Inc. is a distributor of leading industrial chemicals, machinery & equipment. Sky Teck Labs has been committed to providing its customer's with problem solving products. Sky Teck Labs Inc. is a trusted supplier of industrial and municipal chemicals. We have a diverse portfolio of raw materials for manufacturing as well as products for maintenance and lubrication. We offer quality replacement parts and service for turbines.
As the nation's leading environmental testing firm, EMSL's network of nationwide laboratories has been providing quality analytical services since 1981. We offer a wide array of analytical testing services to support environmental investigations focused on asbestos, microbiology, lead paint, environmental chemistry, indoor air quality, industrial hygiene and food testing. Additionally, we also provide materials testing, characterization, and forensic laboratory services for a wide range of commercial, industrial, regulatory, and law enforcement clients. Our unmatched capacity coupled with a company-wide focus on customer satisfaction makes no project too large or too small.
ILC Micro-Chem - our name reflects the combining of services provided by the former Industrial Laboratories and Micro-Chem Laboratories. We have now consolidated the two locations in Mississauga into one large location at 6535 Millcreek Drive (Unit #62).ILC Micro-Chem is ISO/IEC 17025: 2005 accredited through the Standards Council of Canada to provide a scope of chemical, microbiological and instrumental analyses to Canadian, US and overseas clients.ILC is committed to helping clients address compliance issues and growing consumer demand for better information on food produced for human and animal consumption. ILC provides consultation and confirmation for regulatory compliance as required by various government levels.In this era of health and nutrition, consumers are constantly looking for information that will assure them of a healthy and balanced diet.